RecruitingNCT07006831

A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population


Sponsor

Devyser Inc.

Enrollment

400 participants

Start Date

Nov 14, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this research is to collect blood samples and data from kidney transplant patients. The samples and data will be used for research and development of non-invasive test to detect donor-derived cell-free DNA (dd-cfDNA) in kidney transplant patients to evaluate the status of the transplanted organ.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Willing and able to provide written informed consent
  • Is 18 years of age or older at enrollment
  • Had a kidney transplant prior to enrollment
  • Is having an indication (for cause) biopsy as determined by clinician
  • retrospective leftover samples are available from the kidney donor(s).

Exclusion Criteria6

  • Is pregnant
  • Had a blood transfusion within the past 4 weeks
  • Had a transplant from an identical (monozygotic) twin
  • Had transplants of multiple organs from the same donor (eg, kidney and liver transplant).
  • Had transplants of more than 2 organs from different donors (eg, recipient of a third kidney transplant)
  • Had a transplant of hematopoietic stem cells (eg, bone marrow) or tissue (eg, heart valve)

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(6)

Scripps Health

San Diego, California, United States

University of California San Francisco

San Francisco, California, United States

Piedmont Healthcare

Atlanta, Georgia, United States

University of Maryland Baltimore

Baltimore, Maryland, United States

Brigham & Women's Hospital

Boston, Massachusetts, United States

University of Utah

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07006831


Related Trials